Parallax Volatility Advisers’s NxStage Medical Inc. NXTM Stock Holding History

Parallax Volatility Advisers’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,000	Closed	-$315K	–	4541
2018 Q4	$315K	Buy	+11,000	New	+$312K	﹤0.01%	1627
2018 Q2	–	Sell	-69,976	Closed	-$1.74M	–	3798
2018 Q1	$1.74M	Sell	69,976 -10,766	-13%	-$262K	﹤0.01%	812
2017 Q4	$1.96M	Buy	80,742 +7,356	+10%	+$194K	﹤0.01%	922
2017 Q3	$2.02M	Buy	73,386 +71,756	+4,402%	+$1.91M	﹤0.01%	842
2017 Q2	$41K	Buy	+1,630	New	+$40.4K	﹤0.01%	1836
2015 Q3	–	Sell	-9,018	Closed	-$129K	–	4692
2015 Q2	$129K	Buy	+9,018	New	+$153K	﹤0.01%	2159

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Parallax Volatility Advisers's NXTM Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 11,000 shares — an estimated $315K sold.

Parallax Volatility Advisers first reported a position in NXTM in Q2 2015 and held it in 6 quarters. The position peaked at $2.02M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Parallax Volatility Advisers reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 11,000 NxStage Medical Inc. shares in Q1 2019, an estimated $315K.
Parallax Volatility Advisers first reported a position in NxStage Medical Inc. in Q2 2015 and held it in 6 quarters.
Parallax Volatility Advisers's NxStage Medical Inc. position peaked at $2.02M in Q3 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.